Related Experiment Video
Updated: Aug 7, 2026

Using In Vivo and Tissue and Cell Explant Approaches to Study the Morphogenesis and Pathogenesis of the Embryonic and Perinatal Aorta
Published on: September 12, 2017
Novel mutations in the human elastin gene (ELN) causing isolated supravalvular aortic stenosis
Seonmin Park1, Eul-Ju Seo, Han-Wook Yoo
1Genome Research Center for Birth Defects and Genetic Disorders, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Korea.
Researchers identified two novel mutations in the elastin gene (ELN) causing supravalvular aortic stenosis (SVAS). Findings confirm elastin haploinsufficiency as the cause of SVAS, regardless of ethnicity.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Molecular Biology
Background:
- Supravalvular aortic stenosis (SVAS) is an inherited vascular disease.
- Mutations in the elastin gene (ELN) are the known cause of SVAS.
Purpose of the Study:
- Identify novel mutations in the ELN gene in patients with SVAS.
- Determine the expression levels of ELN in SVAS patients.
Main Methods:
- PCR-directed sequence analysis of genomic DNA from SVAS patients and controls.
- Real-time PCR and Western blot analysis of ELN mRNA and protein levels in fibroblast cultures.
Main Results:
- Two novel ELN mutations (G297_A308del and Q700X) were identified in two unrelated Korean SVAS patients.
- Elastin protein levels were reduced by approximately 50% in one patient and <50% in another.
- Elastin mRNA levels were unaffected in one patient but reduced in the other.
Conclusions:
- Functional haploinsufficiency of elastin causes isolated SVAS.
- These findings are applicable across different ethnic backgrounds.
Related Concept Videos
Mitral Stenosis I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
